Flotek Industries raised its full-year 2026 guidance for the second time in five weeks, citing strong international chemistry sales, and its shares rose 6.7% in pre-market trading. The company now expects revenue of $360M-$370M, up from its August 4 range of $340M-$350M and above the $345M FactSet consensus, and adjusted EBITDA of $50M-$54M, raised from $47M-$51M. At the midpoints, these figures would represent increases of 54% and 58% over 2025. Flotek reported that Q2 international chemistry revenue surged more than 450% quarter-over-quarter to $10.6M, and it anticipates H2 sales could exceed $40M, supported by ongoing work in Saudi Arabia and growth in its data analytics segment.
Flotek Industries IncRaises 2026 guidance on strong international chemistry sales, with Q2 international revenue up 450% q/q.
